The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Abbott Laboratories (NYSE:ABT) ...

Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

If you are wondering whether Abbott Laboratories is offering fair value at around US$112.65 per share, you are not alone. This article is designed to help you make sense of what that price might ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...

"Boring" may be just what the doctor ordered in this volatile market.

Abbott stock skidded Wednesday after the S&P 500 health giant missed the Street's third-quarter sales forecast, but met earnings expectations and reiterated its full-year guidance. The sales miss is ...

The stock's fall snapped a three-day winning streak.

Shares of Abbott Laboratories (NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away ...

A trial is set to begin on Wednesday in Chicago in a case brought by four families who allege that baby ​formula made by Abbott Laboratories caused their premature infants to develop a dangerous bowel ...

Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...